Art

J-GLOBAL ID：201102279993215435   Reference number：11A1788165

Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study

ゲムシタビン不応性膵臓癌患者におけるセカンドライン化学療法としてのパクリタキセル:後向き研究

Author (12)： MAEDA Shimpei (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  MOTOI Fuyuhiko (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  ONOGAWA Tohru (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  MORIKAWA Takanori (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  SHIGERU Ottomo (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  SAKATA Naoaki (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  TAKADATE Tatsuyuki (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  NAITOH Takeshi (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  RIKIYAMA Toshiki (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  KATAYOSE Yu (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  EGAWA Shinichi (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN) ,  UNNO Michiaki (Tohoku Univ. Graduate School of Medicine, Miyagi, JPN)
Material： International Journal of Clinical Oncology  (Int J Clin Oncol)
Volume： 16  Issue： 5  Page： 539-545  Publication year： Oct. 2011 
JST Material Number： L3966A  ISSN： 1341-9625  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *drug therapy ,...
Semi thesaurus term： Salvage Therapy ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1788165&from=J-GLOBAL&jstjournalNo=L3966A") }}

JST classification (3)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (2)： Gemcitabine ,  Paclitaxel

Reference (28)：

• JEMAL, A. Cancer statistics, 2009. CA Cancer J Clin. 2009, 59, 225-249
• MATSUDA, T. Cancer incidence and incidence rates in Japan in 2003 : based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol. 2009, 39, 850-858
• BURRIS, HA 3rd. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : a randomized trial. J Clin Oncol. 1997, 15, 2403-2413
• MATSUNO, S. Pancreatic Cancer Registry in Japan : 20 years of experience. Pancreas. 2004, 28, 219-230
• UENO, H. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer : Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer. 2009, 101, 908-915

Terms in the title (6)： ゲムシタビン ,  膵臓癌 ,  患者 ,  セカンドライン化学療法 ,  パクリタキセル ,  研究